Non-invasive Glioma Characterization Through Molecular Imaging



Status:Recruiting
Conditions:Brain Cancer, Brain Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:2/17/2019
Start Date:January 25, 2019
End Date:January 2022

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Pilot Study for Non-invasive Glioma Characterization Through Molecular Imaging

MRI-based sequences can provide non-invasive quantification of intratumoral
2-hydroxyglutarate (2HG) distribution and tumor cellularity in human gliomas and help guide
the development of novel glioma therapies.

This is a pilot study aiming at developing and optimizing MRI-based sequences to provide
non-invasive quantification of intratumoral 2-hydroxyglutarate (2HG) distribution and tumor
cellularity in human gliomas and help guide the development of novel glioma therapies.

Inclusion Criteria:

- Adults (≥18 year old)

- Subjects with suspected or confirmed gliomas and who will have a medically indicated
biopsy or resection of his/her brain lesion.

Exclusion Criteria:

- Adults unable to consent

- Individuals who are not yet adults (infants, children, teenagers)

- Pregnant women

- Patients unable to have MRI done
We found this trial at
1
site
University of Miami
Miami, Florida 33124
(305) 284-2211
Principal Investigator: Macarena De La Fuente, MD
Phone: 305-243-4951
University of Miami A private research university with more than 15,000 students from around the...
?
mi
from
Miami, FL
Click here to add this to my saved trials